Given that Chen et al. [10] found that p-16 negative locally advanced head and neck squamous cell carcinoma patients with RPN2 overexpression exhibited poor responses to induction chemotherapy, and revealed a shorter survival, we hypothesized that RPN2 might be a carcinogenic gene in LSCC. This evidence concerns the gene RPN2 and head and neck squamous cell carcinoma.